As of June 1, 2003, the Exeter Life Sciences Fund ranked first in its category for three-year performance, handily beating the S&P 500. Jeff Herrmann and Brian Lester, analysts at Rochester, NY-based Manning & Napier, which acts as the fund's advisor, explained their approach to investing in this broad and
